HJGA
GMAB icon

Hardman Johnston Global Advisors’s Genmab GMAB Stock Holding History

Hardman Johnston Global Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-226,911
Closed -$4.44M – 77
2025
Q1 		$4.44M Buy
226,911
+12,439
+6% +$261K 0.21% 51
2024
Q4 		$4.48M Sell
214,472
-13,487
-6% -$296K 0.18% 54
2024
Q3 		$5.56M Sell
227,959
-6,263
-3% -$167K 0.22% 51
2024
Q2 		$5.89M Sell
234,222
-28,267
-11% -$801K 0.23% 50
2024
Q1 		$7.85M Sell
262,489
-220,168
-46% -$6.47M 0.27% 50
2023
Q4 		$15.4M Sell
482,657
-109,661
-19% -$3.44M 0.49% 44
2023
Q3 		$20.9M Sell
592,318
-30,089
-5% -$1.15M 0.7% 38
2023
Q2 		$23.7M Buy
622,407
+37,268
+6% +$1.49M 0.77% 40
2023
Q1 		$22.1M Sell
585,139
-19,843
-3% -$763K 0.72% 40
2022
Q4 		$25.6M Sell
604,982
-239,627
-28% -$9.87M 1% 35
2022
Q3 		$27.1M Sell
844,609
-88,840
-10% -$3.12M 1.22% 31
2022
Q2 		$30.3M Sell
933,449
-48,638
-5% -$1.58M 1.29% 26
2022
Q1 		$35.5M Sell
982,087
-25,757
-3% -$884K 1.14% 26
2021
Q4 		$39.9M Sell
1,007,844
-71,425
-7% -$2.98M 1.08% 25
2021
Q3 		$47.2M Buy
1,079,269
+10,013
+0.9% +$450K 1.27% 19
2021
Q2 		$43.7M Buy
1,069,256
+352,610
+49% +$13.6M 1.06% 19
2021
Q1 		$23.5M Sell
716,646
-343,330
-32% -$12.9M 0.67% 37
2020
Q4 		$43.1M Buy
1,059,976
+7,380
+0.7% +$276K 1.25% 19
2020
Q3 		$38.5M Buy
1,052,596
+367,480
+54% +$13.3M 1.44% 18
2020
Q2 		$23.2M Buy
+685,116
New +$18.7M 1.02% 30

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Hardman Johnston Global Advisors's GMAB Position: Q2 2025 in Review

Hardman Johnston Global Advisors sold out of Genmab (GMAB) in Q2 2025, closing a stake of 226,911 shares — an estimated $4.44M sold.

Hardman Johnston Global Advisors first reported a position in GMAB in Q2 2020 and held it in 20 quarters. The position peaked at $47.2M in Q3 2021. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Hardman Johnston Global Advisors reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 226,911 Genmab shares in Q2 2025, an estimated $4.44M.
  • Hardman Johnston Global Advisors first reported a position in Genmab in Q2 2020 and held it in 20 quarters.
  • Hardman Johnston Global Advisors's Genmab position peaked at $47.2M in Q3 2021.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Hardman Johnston Global Advisors's 13F filing for Q2 2025, filed 21 Jul 2025.